| Therapy . | n (%) . |
|---|---|
| Combination therapy | |
| Monotherapy | 47 (66) |
| Combination | 24 (34) |
| Therapeutic agent | |
| Bicalutamide | 4 (17) |
| Abiraterone | 8 (35) |
| Enzalutamide | 10 (43) |
| Apalutamide | 3 (13) |
| Docetaxel | 1 (4) |
| Cabazitaxel | 2 (9) |
| Radium 223 | 1 (4) |
| Therapy . | n (%) . |
|---|---|
| Combination therapy | |
| Monotherapy | 47 (66) |
| Combination | 24 (34) |
| Therapeutic agent | |
| Bicalutamide | 4 (17) |
| Abiraterone | 8 (35) |
| Enzalutamide | 10 (43) |
| Apalutamide | 3 (13) |
| Docetaxel | 1 (4) |
| Cabazitaxel | 2 (9) |
| Radium 223 | 1 (4) |
| Therapy . | n (%) . |
|---|---|
| Combination therapy | |
| Monotherapy | 47 (66) |
| Combination | 24 (34) |
| Therapeutic agent | |
| Bicalutamide | 4 (17) |
| Abiraterone | 8 (35) |
| Enzalutamide | 10 (43) |
| Apalutamide | 3 (13) |
| Docetaxel | 1 (4) |
| Cabazitaxel | 2 (9) |
| Radium 223 | 1 (4) |
| Therapy . | n (%) . |
|---|---|
| Combination therapy | |
| Monotherapy | 47 (66) |
| Combination | 24 (34) |
| Therapeutic agent | |
| Bicalutamide | 4 (17) |
| Abiraterone | 8 (35) |
| Enzalutamide | 10 (43) |
| Apalutamide | 3 (13) |
| Docetaxel | 1 (4) |
| Cabazitaxel | 2 (9) |
| Radium 223 | 1 (4) |
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
